137 related articles for article (PubMed ID: 38225622)
1. Melanoma of the central nervous system based on neurocutaneous melanocytosis in childhood: A rare but fatal condition.
Abele M; Forchhammer S; Eigentler TK; Popescu A; Maschke L; Lohse J; Lehrnbecher T; Behnisch W; Groll AH; Jakob M; Bernbeck B; Brecht IB; Schneider DT
Pediatr Blood Cancer; 2024 Apr; 71(4):e30859. PubMed ID: 38225622
[TBL] [Abstract][Full Text] [Related]
2. Druggable targets in pediatric neurocutaneous melanocytosis: Molecular and drug sensitivity studies in xenograft and ex vivo tumor cell culture to identify agents for therapy.
Ruan Y; Kovalchuk A; Jayanthan A; Lun X; Nagashima Y; Kovalchuk O; Wright JR; Pinto A; Kirton A; Anderson R; Narendran A
Neuro Oncol; 2015 Jun; 17(6):822-31. PubMed ID: 25395461
[TBL] [Abstract][Full Text] [Related]
3. Large congenital melanocytic nevi and the risk for development of malignant melanoma and neurocutaneous melanocytosis.
Bittencourt FV; Marghoob AA; Kopf AW; Koenig KL; Bart RS
Pediatrics; 2000 Oct; 106(4):736-41. PubMed ID: 11015516
[TBL] [Abstract][Full Text] [Related]
4. Experimental treatment of NRAS-mutated neurocutaneous melanocytosis with MEK162, a MEK-inhibitor.
Küsters-Vandevelde HV; Willemsen AE; Groenen PJ; Küsters B; Lammens M; Wesseling P; Djafarihamedani M; Rijntjes J; Delye H; Willemsen MA; van Herpen CM; Blokx WA
Acta Neuropathol Commun; 2014 Apr; 2():41. PubMed ID: 24713450
[TBL] [Abstract][Full Text] [Related]
5. Association of melanoma and neurocutaneous melanocytosis with large congenital melanocytic naevi--results from the NYU-LCMN registry.
Hale EK; Stein J; Ben-Porat L; Panageas KS; Eichenbaum MS; Marghoob AA; Osman I; Kopf AW; Polsky D
Br J Dermatol; 2005 Mar; 152(3):512-7. PubMed ID: 15787820
[TBL] [Abstract][Full Text] [Related]
6. Neurocutaneous Melanocytosis and Leptomeningeal Melanoma.
Mitre V; Heym K; Clark GD; Venkatramani R
J Pediatr Hematol Oncol; 2021 Mar; 43(2):e195-e197. PubMed ID: 31764519
[TBL] [Abstract][Full Text] [Related]
7. Neurocutaneous melanocytosis (melanosis).
Ruggieri M; Polizzi A; Catanzaro S; Bianco ML; Praticò AD; Di Rocco C
Childs Nerv Syst; 2020 Oct; 36(10):2571-2596. PubMed ID: 33048248
[TBL] [Abstract][Full Text] [Related]
8. NRAS
Girolami I; Cima L; Ghimenton C; Zannoni M; Mombello A; Riva G; Cirielli V; Corradi G; Vogrig A; Di Stefano G; Novelli L; Gessi M; Eccher A
Brain Tumor Pathol; 2018 Oct; 35(4):217-223. PubMed ID: 30145692
[TBL] [Abstract][Full Text] [Related]
9. Spectrum of central nervous system abnormalities in neurocutaneous melanocytosis.
Ramaswamy V; Delaney H; Haque S; Marghoob A; Khakoo Y
Dev Med Child Neurol; 2012 Jun; 54(6):563-8. PubMed ID: 22469364
[TBL] [Abstract][Full Text] [Related]
10. Neurosurgical management of patients with neurocutaneous melanosis: a systematic review.
Rahman RK; Majmundar N; Ghani H; San A; Koirala M; Gajjar AA; Pappert A; Mazzola CA
Neurosurg Focus; 2022 May; 52(5):E8. PubMed ID: 35535823
[TBL] [Abstract][Full Text] [Related]
11. Severe hydrocephalus caused by diffuse leptomeningeal and neurocutaneous melanocytosis of antenatal onset: a clinical, pathologic, and molecular study of 2 cases.
Uguen A; Laurent C; Samaison L; Boisselier B; Talagas M; Costa S; Aziza J; Mokhtari K; Le Maréchal C; Marcorelles P
Hum Pathol; 2015 Aug; 46(8):1189-96. PubMed ID: 26037215
[TBL] [Abstract][Full Text] [Related]
12. Metastatic peritoneal neurocutaneous melanocytosis.
Cajaiba MM; Benjamin D; Halaban R; Reyes-Múgica M
Am J Surg Pathol; 2008 Jan; 32(1):156-61. PubMed ID: 18162783
[TBL] [Abstract][Full Text] [Related]
13. Amplification of mutated NRAS leading to congenital melanoma in neurocutaneous melanocytosis.
Salgado CM; Basu D; Nikiforova M; Hamilton RL; Gehris R; Jakacki R; Panigrahy A; Yatsenko S; Reyes-Múgica M
Melanoma Res; 2015 Oct; 25(5):453-60. PubMed ID: 26266759
[TBL] [Abstract][Full Text] [Related]
14. Neurocutaneous Melanosis in an Adult Patient with Intracranial Primary Malignant Melanoma: Case Report and Review of the Literature.
Ma M; Ding ZL; Cheng ZQ; Wu G; Tang XY; Deng P; Wu JD
World Neurosurg; 2018 Jun; 114():76-83. PubMed ID: 29530698
[TBL] [Abstract][Full Text] [Related]
15. Leptomeningeal melanoma in childhood.
Makin GW; Eden OB; Lashford LS; Moppett J; Gerrard MP; Davies HA; Powell CV; Campbell AN; Frances H
Cancer; 1999 Sep; 86(5):878-86. PubMed ID: 10463989
[TBL] [Abstract][Full Text] [Related]
16. Copy number abnormalities in new or progressive 'neurocutaneous melanosis' confirm it to be primary CNS melanoma.
Kinsler VA; Polubothu S; Calonje JE; Chong WK; Thompson D; Jacques TS; Morrogh D
Acta Neuropathol; 2017 Feb; 133(2):329-331. PubMed ID: 27933403
[No Abstract] [Full Text] [Related]
17. Missense mutation of NRAS is associated with malignant progression in neurocutaneous melanosis.
Takahashi H; Natsumeda M; Hara N; Koyama A; Shimizu H; Miyashita A; Satake D; Mouri Y; Tsukano J; Kawabe K; Tsukamoto Y; Okada M; Ogura R; Yuki A; Umezu H; Kakita A; Ikeuchi T; Oishi M
Acta Neuropathol Commun; 2024 Jan; 12(1):14. PubMed ID: 38254245
[TBL] [Abstract][Full Text] [Related]
18. Clinical Follow-Up of Patients with Neurocutaneous Melanosis in a Tertiary Center; Proposed Modification in Diagnostic Criteria.
Habibi Z; Ebrahimi H; Meybodi KT; Yaghmaei B; Nejat F
World Neurosurg; 2021 Feb; 146():e1063-e1070. PubMed ID: 33246180
[TBL] [Abstract][Full Text] [Related]
19. Multiple congenital melanocytic nevi and neurocutaneous melanosis are caused by postzygotic mutations in codon 61 of NRAS.
Kinsler VA; Thomas AC; Ishida M; Bulstrode NW; Loughlin S; Hing S; Chalker J; McKenzie K; Abu-Amero S; Slater O; Chanudet E; Palmer R; Morrogh D; Stanier P; Healy E; Sebire NJ; Moore GE
J Invest Dermatol; 2013 Sep; 133(9):2229-36. PubMed ID: 23392294
[TBL] [Abstract][Full Text] [Related]
20. Neurocutaneous melanosis presenting with hydrocephalus and malignant transformation: case-based update.
Sharouf F; Zaben M; Lammie A; Leach P; Bhatti MI
Childs Nerv Syst; 2018 Aug; 34(8):1471-1477. PubMed ID: 29948137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
